Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Department of Internal Related

Kobe University Graduate School of Medicine

Japan

Name/email consistency: high

Department of Internal Related, Kobe University Graduate School of Medicine, Japan. 2000 - 2010
Division of Dermatology, Department of Clinical Molecular Medicine Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Japan. 2004 - 2009

Antitumor activities of interleukin-27 on melanoma. Nagai, H., Oniki, S., Fujiwara, S., Xu, M., Mizoguchi, I., Yoshimoto, T., Nishigori, C. Endocr. Metab. Immune. Disord. Drug. Targets (2010) [Pubmed]
Induction of cellular immunity against hair follicle melanocyte causes alopecia. Nagai, H., Oniki, S., Oka, M., Horikawa, T., Nishigori, C. Arch. Dermatol. Res. (2006) [Pubmed]
In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer. Nagai, H., Horikawa, T., Hara, I., Fukunaga, A., Oniki, S., Oka, M., Nishigori, C., Ichihashi, M. Exp. Dermatol. (2004) [Pubmed]
Gene transfer of secreted-type modified interleukin-18 gene to B16F10 melanoma cells suppresses in vivo tumor growth through inhibition of tumor vessel formation. Nagai, H., Hara, I., Horikawa, T., Oka, M., Kamidono, S., Ichihashi, M. J. Invest. Dermatol. (2002) [Pubmed]
Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration. Nagai, H., Hara, I., Horikawa, T., Oka, M., Kamidono, S., Ichihashi, M. J. Invest. Dermatol. (2000) [Pubmed]